Cassava is stopping all development of simufilam in Alzheimer’s disease. Image credit: Shutterstock / Mikadun. Cassava Sciences has officially stopped the development of its investigational drug ...

Cassava Technologies has announced plans to build Africa’s first “AI Factory” — a high-performance, AI-enabled data center powered by NVIDIA’s advanced computing technology. At the ...

Islam may be most commonly associated with the Arab world, but its roots run deep across many parts of the globe, notably in ...

Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era defined by controversy and failed clinical trials. The company reported the ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

Cassava Technologies has tapped Nvidia to build Africa’s first artificial intelligence "factory". Cassava Technologies, founded by Zimbabwean telecommunications tycoon Strive Masiyiwa, has tapped ...

Cassava Technologies has announced plans to construct Africa’s first AI factory, a state-of-the-art data center facility equipped with NVIDIA’s advanced AI computing technology. The initiative aims to ...

A tourist in Mexico is facing charges after he climbed stairs of one of the New Seven Wonders of the World before furious locals took justice into their own hands by beating the man. Bystander ...

Global technology firm, Cassava Technologies, will partner American multinational corporation and technology company, Nvidia Corporation, to build Africa’s first artificial intelligence (AI ...

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified ...